Published in TB and Outbreaks Week, September 1st, 1997
Prophylaxis of most opportunistic infections in HIV infected patients requires lifelong administration of an effective drug. The effects of isoniazid in the prevention of TB in HIV infected patients with relatively preserved immunity has been established in retrospective and prospective studies, but the long-term efficacy of the drug is unknown.
"Some researchers have suggested the administration of isoniazid...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.